Marcos Jose Garcia De Lima MD

PubMed

• 7 citations
  Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome.
  Omar H Butt, Alice Y Zhou, Paolo F Caimi, Patrick H Luckett, Julie K Wisch
  JAMA Oncology. 2022-11-01
• 1 citations
  Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploi...
  Folashade Otegbeye, Marcelo A Fernandez Vina, Tao Wang, Yung-Tsi Bolon, Aleksandr Lazaryan
  Transplantation and Cellular Therapy. 2022-08-01
• 3 citations
  Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation.
  Naveed Ali, Ashish Arunkumar Sharma, Ana Carolina Pires de Rezende, Folashade Otegbeye, Bilal Muhammad Latif
  Transplantation and Cellular Therapy. 2022-07-01

Lectures

• Preclinical Studies and a Phase I Trial of the TGF-β Receptor Inhibitor, Vactosertib (TEW-7197), in Combination with Pomalidomide in Patients with Multiple Myeloma Ref... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• The Direction of KIR Ligand Incompatibility Is Associated with Graft Failure and May Predict the Dominant Donor Following Double Umbilical Cord Blood Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Impact of Maintenance Therapy on Nature of First Relapse in Multiple Myeloma Patients Underwent Autologous Stem Cell Transplant 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Phase I Trial of Carfilzomib + R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Vactosertib, a TGF-ß Receptor I Kinase/ALK5 Inhibitor, Diminishes Tumor Progression and Bone Disease in a Mouse Model of Multiple Myeloma and Overcomes Resistance to P... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Automated Generation and Phenotypic Characterization of Clinical Grade CD19 CAR-T Cells 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Comparison of Pegfilgrastim and Filgrastim to Prevent Neutropenic Fever during Consolidation with High Dose Cytarabine for Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies in Acute Myeloid Leukemia (AML) Patients 60-75 Years of Age in First Complete R... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all